Systematic review / meta-analysis / 2007
Glucosamine efficacy for osteoarthritis pain varied widely and was higher in trials with industry involvement and those testing glucosamine sulfate.
A meta-analysis evaluated 15 randomized, double-blind, placebo-controlled trials of glucosamine for knee or hip osteoarthritis pain to identify factors explaining trial heterogeneity. The overall summary effect size was 0.35 (95% CI 0.14, 0.56) with substantial heterogeneity (I² = 0.80). Summary effect sizes ranged from 0.05 to 0.16 in trials without industry involvement versus 0.47 to 0.55 in trials with industry involvement. By preparation, the effect size was 0.06 for glucosamine hydrochloride and 0.44 for glucosamine sulfate (0.55 for Rottapharm products vs. 0.11 for others). Potential explanations for heterogeneity include different glucosamine preparations, inadequate allocation concealment, and industry bias.
- Study type
- Meta-analysis of randomized, double-blind, placebo-controlled trials
- Who was studied
- Participants with knee or hip osteoarthritis across 15 randomized controlled trials
- What was measured
- Osteoarthritis pain and factors explaining heterogeneity in effect sizes
THE PAPER
Glucosamine for pain in osteoarthritis: why do trial results differ?
Vlad SC, LaValley MP, McAlindon TE, Felson DT. Arthritis Rheum, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.